Pregled bibliografske jedinice broj: 776525
Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes
Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes // Diabetologia 2015 ; 58 (Suppl. 1): S532-S533.
Stockholm, Švedska, 2015. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 776525 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes
Autori
Bulum, Tomislav ; Blaslov, Kristina ; Tomić, Martina ; Duvnjak, Lea
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Diabetologia 2015 ; 58 (Suppl. 1): S532-S533.
/ - , 2015
Skup
51st EASD Annual Meeting
Mjesto i datum
Stockholm, Švedska, 14.09.2015. - 18.09.2015
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
glucagon-like peptide-1; albuminuria; type 2 diabetes
Sažetak
The results of our study suggest that therapy with GLP-1 receptor agonists liraglutide and exenatidemay significantly reduce UAE in overweight T2DM. It has been suggested that GLP-1 receptor agonists has a crucial role in protection against increased renal oxidative stress under chronic hyperglycemia via inhibition of NAD(P)H oxidase and PKA activation which resulted in reduced albuminuria and mesangial expansion.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
